Amy Jacob

"Left heart remodeling after transcatheter aortic valve replacement (TAVR) is poorly characterized," according to Marco Magalhaes, MD, who presented at the American Heart Association (AHA) Scientific Sessions 2014.

Researchers from the Mayo Clinic recently reported, at the American Association for the Study of Liver Diseases (The Liver Meeting 2014), in Boston, MA, on the safety and efficacy in post-liver transplant of 2 new oral medications, simeprevir and sofosbuvir, within a 12-week treatment span.

A recent study led by researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine has shown that aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) protect against the development of colorectal cancer through cell suicide pathway induction in intestinal stem cells that carry a certain mutated gene.

Serum-derived bovine immunoglobulin/protein isolate appears to be a safe and effective nutritional moiety in patients with refractory IBS-D or IBS-M.

According to a recent study published in Radiology, computed tomographic (CT) findings may be able to predict the efficacy of nonsurgical treatment in patients afflicted with adhesive small-bowl obstruction.

Results from a phase 2 trial, published recently in The New England Journal of Medicine, suggest that treatment with 150 mg of nintedanib slowed lung-function decline and decreased acute exacerbations in patients with idiopathic pulmonary fibrosis.

"All kinds of obesity cause asthma," declared Akshay Sood, MBBS, FCCP during his presentation at CHEST 2014. In the scope of synergistic epidemics, the question of what kind of obesity causes asthma is a rather relevant one.

In a presentation delivered at CHEST 2014, Edward Kerwin, MD, discussed the safety and efficacy of the twice-daily COPD treatment SUN-101, a glycopyrrolate inhalation solution delivered via nebulizer.

Stephen Rennard, MD, and his team focused their study on the assessment of long-term efficacy and safety of aclidinium bromide 400µg BID, an approved treatment option for patients afflicted with moderate to severe COPD.

Richard ZuWallack, MD, a specialist in pulmonary rehabilitation from St. Francis Hospital and Medical Center in Hartford, CT, presented results from 2 studies highlighting lung function improvement in patients with chronic obstructive pulmonary disease (COPD).

During a presentation at CHEST 2014, Marcos Restrepo, MD, FCCP, reviewed the data showing a link between inhaled corticosteroids and the risk of pneumonia. He also discussed the types of inhaled corticosteroids and the dose that is associated most with the development of pneumonia, as well as what impact they may have on clinical outcomes.

Xi E. Zheng, MD, PhD, shares her views on young-onset colorectal cancer at 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Monika Fischer, MD, talks about focusing research on patients with more severe IBD symptoms at 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Monika Fischer, MD, discusses the outcomes of a study assessing fecal microbiota transplantation for c. difficile infection at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.

Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Charles Bernstein, MD, FACG, discusses his research on Inflammatory Bowel Disease (IBD) treatment at the 2014 ACG Annual Meeting in Philadelphia, PA.

John Saltzman, MD, Director of Endoscopy, Brigham and Women's Hospital, shares his experiences and thoughts on endoscopy testing and other topics discussed at the 2014 ACG Annual Meeting in Philadelphia, PA.

John Saltzman, MD, discusses the gastrointestinal tract and the integration of novel gastrointestinal procedures into treatment, and the role of the human microbiome in relation to GI disorders.

Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.

Researchers are looking for the next best non-invasive and safe alternatives to fight infections. Although unconventional, a preliminary study published in the Journal of the American Medical Association revealed the successful strides researchers have made to cure patients suffering from recurrent C. Difficile infection (CDI) using oral frozen fecal matter treatment.

The US Food and Drug Administration (FDA) today approved Akynzeo to treat cancer chemotherapy related nausea and sickness.

Researchers in Barcelona, Spain, have recently developed a fruit fly, Drosophila melanogaster, with colon cancer that aids in identifying significant genetic factors within human intestinal cancer.

Uceris (budesonide) is now approved in a new dose for the induction of remission in patients afflicted with active mild-to-moderate distal ulcerative colitis.

A Canadian research team has discovered a rare disease named Chronic Atrial Intestinal Dysrhythmia syndrome (CAID) caused by a unique genetic mutation that affects both intestinal tract and heart rates.

Scientists in Germany have discovered a causal relationship between psychological factors and symptoms of irritable bowel syndrome (IBS) after viewing high rates of anxiety and depression among IBS patients.

Humira (adalimumab) is now indicated to treat children age 6 years and older with moderately to severely active Crohn's disease who have had an inadequate response to treatment with corticosteroids or immunomodulators.

After conducting a population-based, nationwide cohort study, researchers reported a relationship between inflammatory bowel disease (IBD), especially Crohn's disease (CD), and cervical neoplasia.

As more studies have demonstrated potential therapeutic applications for marijuana, public opinion regarding medical and recreational marijuana use has shifted. One such study recently published in the American Journal of Gastroenterology revealed medical marijuana is potentially beneficial for digestive disorders and gastrointestinal symptoms.

Advances in knowledge surrounding gastrointestinal conditions have paved the way for improvements in Crohn's disease (CD) treatment. To aid clinicians in managing patients with CD, the American Gastroenterological Association (AGA) created a clinical decision tool to effectively guide gastroenterologists throughout their decision-making process.